Longeveron Inc. announced it raised $20.5 Million in an initial filing from an offering of $20.5 Million

Dec 13, 2021•over 3 years ago

Amount Raised

$20.5 Million

MiamiBiotechnology

Company Information

Company

Longeveron Inc.

Location

1951 NW 7TH AVENUE

Miami, Florida, United States

About

We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Longeveron Inc. announced it raised $20.5 Million in an initial filing from an offering of $20.5 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information